Walmart’s John Furner connects GLP-1 medications with lower grocery spend — NBCNews.com

By 8th & Walton | on October 5, 2023

Photo by Diana Polekhina on Unsplash

Walmart U.S. is seeing a dip in grocery spending, something that CEO John Furner attributes to the effectiveness of GLP-1 weight loss drugs:

“Walmart’s U.S. CEO, John Furner, told Bloomberg News that the company is seeing signs that people taking GLP-1 agonist appetite suppressant medications are buying ‘less units, slightly less calories.’“

Concerned about your relationship with Walmart? Check out our SQEP Seminar: What You Need to Know.

About the Author

8th & Walton consists of retail industry experts with a combined 200+ years of Walmart and Walmart supplier experience. Having helped hundreds of CPG companies in their efforts to be better supplier partners to the world's most influential retailer, the 8th & Walton editorial team prides itself on being a go-to resource for Walmart supplier news and insights.

Related Content

Three-Minute Thursdays: Store of the Future Expansion with Mark Stallcup

Walmart Open Call 2025: How to Prepare

Three-Minute Thursdays: Retail CEOs meet with the president on tariffs